메뉴 건너뛰기




Volumn 50, Issue 9, 2011, Pages 1009-1013

Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant pseudomonas aeruginosa in patients with hematologic malignancy: A matched pair analysis

Author keywords

Colistin; MDR bacteria; Neutropenia; Neutropenic fever

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; CREATININE; GENTAMICIN; MEROPENEM; METRONIDAZOLE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM; TEICOPLANIN; UREA; VANCOMYCIN;

EID: 79955630668     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4270     Document Type: Article
Times cited : (44)

References (10)
  • 1
    • 33144473431 scopus 로고    scopus 로고
    • Bad bugs need drugs: An update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
    • Talbot GH, Bradley J, Edwards JJE, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668, 2006.
    • (2006) Clin Infect Dis , vol.42 , pp. 657-668
    • Talbot, G.H.1    Bradley, J.2    Edwards, J.J.E.3    Gilbert, D.4    Scheld, M.5    Bartlett, J.G.6
  • 2
    • 0035171243 scopus 로고    scopus 로고
    • Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
    • Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39: 183-190, 2001.
    • (2001) J Clin Microbiol , vol.39 , pp. 183-190
    • Gales, A.C.1    Reis, A.O.2    Jones, R.N.3
  • 3
    • 34447560960 scopus 로고    scopus 로고
    • Toxicity of polymyxins: A systematic review of the evidence from old and recent studies
    • Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10: R27, 2006.
    • (2006) Crit Care , vol.10
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 4
    • 39549102838 scopus 로고    scopus 로고
    • Intravenous colistin sulphomethate sodium for therapy of infections due to multidrugresistant gram-negative bacteria
    • Pintado V, San Miguel LG, Grill F, et al. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrugresistant gram-negative bacteria. J Infect 56: 185-190, 2008.
    • (2008) J Infect , vol.56 , pp. 185-190
    • Pintado, V.1    San Miguel, L.G.2    Grill, F.3
  • 5
    • 46549084905 scopus 로고    scopus 로고
    • Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
    • Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. J Infect 56: 432-436, 2008.
    • (2008) J Infect , vol.56 , pp. 432-436
    • Betrosian, A.P.1    Frantzeskaki, F.2    Xanthaki, A.3    Douzinas, E.E.4
  • 6
    • 0038369924 scopus 로고    scopus 로고
    • Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP
    • Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36: 1111-1118, 2003.
    • (2003) Clin Infect Dis , vol.36 , pp. 1111-1118
    • Garnacho-Montero, J.1    Ortiz-Leyba, C.2    Jimenez-Jimenez, F.J.3
  • 7
    • 33947610931 scopus 로고    scopus 로고
    • Management of a multidrugresistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature
    • Papagelopoulos PJ, Mavrogenis AF, Giannitsioti E, Kikilas A, Kanellakopoulou K, Soucacos PN. Management of a multidrugresistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature. J Arthroplasty 22: 457-463, 2007.
    • (2007) J Arthroplasty , vol.22 , pp. 457-463
    • Papagelopoulos, P.J.1    Mavrogenis, A.F.2    Giannitsioti, E.3    Kikilas, A.4    Kanellakopoulou, K.5    Soucacos, P.N.6
  • 8
    • 34250159829 scopus 로고    scopus 로고
    • Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
    • Hachem RY, Chemaly RF, Ahmar CA, et al. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother 51: 1905-1911, 2007.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 1905-1911
    • Hachem, R.Y.1    Chemaly, R.F.2    Ahmar, C.A.3
  • 9
    • 0026710191 scopus 로고
    • Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
    • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655, 1992.
    • (1992) Chest , vol.101 , pp. 1644-1655
    • Bone, R.C.1    Balk, R.A.2    Cerra, F.B.3
  • 10
    • 0043269792 scopus 로고    scopus 로고
    • An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome
    • Yu VL, Chiou CCC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37: 230-237, 2003.
    • (2003) Clin Infect Dis , vol.37 , pp. 230-237
    • Yu, V.L.1    Chiou, C.C.C.2    Feldman, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.